Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Carboplatin With or Without Anthracycline in Advanced Endometrial Carcinoma
NCT06102252Completed
- Sponsor
- Sohag University
- Start
- Aug 2024
- Primary completion
- Nov 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised trial of epirubicin in endometrial carcinoma (3 arms), sponsored by Sohag University. Primary endpoint: Completion rate of chemotherapy at 6 months. Started Aug 2024; status: completed.
02
Drugs
epirubicin
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT06102252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06102252.